Axa PPP Provides Medical Cover for Abiraterone
It has been recently revealed that the second largest private medical insurance company in the UK has changed its opinion on Abiraterone, a drug used to treat patients suffering from advanced prostate cancer.
Axa PPP has announced that it would be providing medical insurance cover for the drug and would be paying for it. Confirming the news Axa PPP spokesperson said that they have gone in line with Bupa and WPA as they think that it would be right thing to do.
The company is the latest entrant in the list of policy insurance companies which provide insurance for the drug. Another two companies which provide Abiraterone are Bupa and WPA. Both of the companies pay £3,000 a month for a single patient.
Dr.
Recent Comments